Universe Pharmaceuticals INC (UPC)
NASDAQ: UPC · IEX Real-Time Price · USD
2.900
+0.470 (19.34%)
At close: Jul 2, 2024, 4:00 PM
2.950
+0.050 (1.72%)
After-hours: Jul 2, 2024, 7:37 PM EDT

UPC Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.
Year
Current20232022202120202019
Market Capitalization
1131252--
Market Cap Growth
-93.36%-71.98%-76.31%---
Enterprise Value
-2-10-334-7-1
PE Ratio
--0.56-1.414.58--
PS Ratio
0.330.110.311.08--
PB Ratio
0.270.090.270.88--
P/FCF Ratio
9.833.20-8.74-3.33--
P/OCF Ratio
9.443.07-9.36-25.23--
EV/Sales Ratio
-0.30-0.30-0.070.72-0.24-0.02
EV/EBITDA Ratio
3.013.010.362.42-0.70-0.06
EV/EBIT Ratio
2.592.590.342.50-0.72-0.07
EV/FCF Ratio
-8.90-8.901.87-2.21-1.22-0.05
Debt / Equity Ratio
0.140.140.080.070.130.20
Debt / EBITDA Ratio
-1.72-1.72-0.540.300.250.25
Debt / FCF Ratio
5.105.10-2.80-0.280.440.19
Quick Ratio
2.142.142.603.602.621.76
Current Ratio
2.682.683.174.502.912.24
Asset Turnover
0.570.570.620.971.32-
Interest Coverage
-23.55-23.55-48.16135.6382.6175.67
Return on Equity (ROE)
-14.30%-14.30%-16.60%28.40%45.50%-
Return on Assets (ROA)
-10.90%-10.90%-13.50%22.90%32.40%-
Return on Capital (ROIC)
-7.83%-7.83%-14.77%17.78%32.72%51.18%
Earnings Yield
-58.29%-178.96%-71.09%21.82%--
FCF Yield
10.18%31.24%-11.44%-30.05%--
Buyback Yield / Dilution
-14.59%--14.59%-18.63%--
Total Shareholder Return
-14.59%--14.59%-18.63%--
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).